Operating revenue increased 11.4% year over year to $4.5 billion for the three months ended March 31. Northwell said the growth was primarily attributable to increases in patient volume, payment rates, pharmacy sales and continued growth in the ambulatory and physician network. Additionally, the system received $142.3 million in COVID-19 relief funding (none was received in the same quarter last year). Revenue cycle initiatives also contributed to the revenue growth.
The system’s operating expenses increased 9% year over year to $4.4 billion. Northwell said the increase was attributable to cost-of-living wage adjustments, the effect on inflation on supply and expense price trends and investments in four areas. Those areas were:
- Facilities and programs to enhance capacity and infrastructure
- Safety, quality and patient experience initiatives
- Ambulatory and physician network expansion
- IT, including investments in EHRs, digital health technology and telehealth services
The health system said expense reduction efforts included implementing productivity and efficiency efforts, program consolidation and supply chain initiatives (such as the continuous review of programs to improve standardization, distribution, utilization and contracting).
Northwell posted a net income of $359.4 million, up from $241.4 million in the same quarter last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
